AU2002253940A1 - Immortalized human familial prostatic cancer cell lines - Google Patents

Immortalized human familial prostatic cancer cell lines

Info

Publication number
AU2002253940A1
AU2002253940A1 AU2002253940A AU2002253940A AU2002253940A1 AU 2002253940 A1 AU2002253940 A1 AU 2002253940A1 AU 2002253940 A AU2002253940 A AU 2002253940A AU 2002253940 A AU2002253940 A AU 2002253940A AU 2002253940 A1 AU2002253940 A1 AU 2002253940A1
Authority
AU
Australia
Prior art keywords
cell lines
cancer cell
prostatic cancer
immortalized human
human familial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002253940A
Inventor
Charles Ewing
William Isaacs
Johng S. Rhim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Original Assignee
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henry M Jackson Foundation for Advancedment of Military Medicine Inc filed Critical Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Publication of AU2002253940A1 publication Critical patent/AU2002253940A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
AU2002253940A 2001-02-13 2002-02-13 Immortalized human familial prostatic cancer cell lines Abandoned AU2002253940A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26806101P 2001-02-13 2001-02-13
US60/268,061 2001-02-13
PCT/US2002/004170 WO2002064018A2 (en) 2001-02-13 2002-02-13 Immortalized human familial prostatic cancer cell lines

Publications (1)

Publication Number Publication Date
AU2002253940A1 true AU2002253940A1 (en) 2002-08-28

Family

ID=23021294

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002253940A Abandoned AU2002253940A1 (en) 2001-02-13 2002-02-13 Immortalized human familial prostatic cancer cell lines

Country Status (2)

Country Link
AU (1) AU2002253940A1 (en)
WO (1) WO2002064018A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610043A (en) * 1994-04-28 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Human prostatic cell lines immortalized by adenovirus 12-simian virus 40 (AD12/SV40) hybrid virus
US5824488A (en) * 1994-04-28 1998-10-20 Board Of Trustees Operating Michigan State University Immortalized and malignant human prostatic cell lines
JP2002510974A (en) * 1997-06-27 2002-04-09 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Human NK-3-related prostate specific gene-1

Also Published As

Publication number Publication date
WO2002064018A2 (en) 2002-08-22
WO2002064018A3 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
AU2002212527A1 (en) Thermometry-based breast cancer risk assessment
AU2002211835A1 (en) Oncology tissue microarrays
AU2002247304A1 (en) Anti-neovasculature preparations for cancer
AU2002242147A1 (en) Payment management
AU2002238101A1 (en) Payment management
AU2002356653A1 (en) Radiotherapy system
AU2002341717A1 (en) Cell therapy system
AU2002367073A1 (en) Constant coverage waveguide
AU2002364708A1 (en) Novel compositions and methods for cancer
AU2002360345A1 (en) Prostate cancer genes
AU2002353402A1 (en) Service access
AU2002307154A1 (en) Prostate cancer expression profiles
AU3178200A (en) Genetic analysis
AU2881301A (en) Cancer cell implantation inhibitors
AU2002244055A1 (en) Fra-1 expression in brain cancer
AU2002362613A1 (en) Galectins-1-and-4 in tumor development
AU2002365938A1 (en) Modified antigen-presenting cells
AU2002337943A1 (en) Novel compositions and methods for cancer
AU2001268163A1 (en) Haplotypes of the ube3a gene
AU2001278068A1 (en) Methods and compositions for predicting prostate cancer
AU2002253940A1 (en) Immortalized human familial prostatic cancer cell lines
AU2002243977A1 (en) Immortalized human prostatic cancer cell lines
AU2002259005A1 (en) Compositions and methods for inducing cancer cell death
AU2002351382A1 (en) Combination cancer therapy
AU4126301A (en) Shower gel

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase